PharmAla Issues Q3 Financial Statements
TORONTO, July 25, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”…
Calidi announces Reverse Stock Split, expected to begin trading on a 1-for-12 split adjusted basis onAugust 5, 2025
SAN DIEGO, July 25, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (“Calidi”…
Ambow Launches HybriU Global Learning Network, Connecting U.S. Universities with Students Worldwide
New Phygital Infrastructure Empowers U.S. Universities to Expand Globally Through AI-powered Hybrid…
Aurora Mobile Leverages Quantum Computing to Accelerate Business Model Innovation
July 25, 2025 05:00 ET | Source: Aurora Mobile Limited SHENZHEN, China,…
Nrburgring chooses vivenu: New partnership accelerates ticketing innovation
DÜSSELDORF, Germany and NÜRBURG, Germany, July 25, 2025 (GLOBE NEWSWIRE) -- Nürburgring,…
Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-Adapted COVID-19 Vaccine in the European Union
Data indicate that the LP.8.1-adapted COVID-19 vaccine confers improved immune response against…
Abivax Announces Full Exercise of Underwriters Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $747.5M (637.5M)
Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing…
Press Release: Sanofis Sarclisa approved in the EU for the treatment of transplant-eligible newly diagnosed multiple myeloma
Sanofi’s Sarclisa approved in the EU for the treatment of transplant-eligible newly…
The Joint Corp. to Host Conference Call on Thursday, August 7thto Discuss Second Quarter 2025 Results
July 24, 2025 07:05 ET | Source: The Joint Corp. SCOTTSDALE, Ariz.,…
INmune Bio to Present Phase 2 MINDFuL Trial Findings of XPro at the Alzheimers Association International Conference
July 24, 2025 07:00 ET | Source: INmune Bio, Inc. Boca Raton,…
